Services

  1. ACMD open meeting registration form

    Complete this form to attend the open meeting of the Advisory Council on the Misuse of Drugs in London.

  2. ACMD open meeting March 2012

    Register for the ACMD open meeting here.

  3. ACMD review on MDMA: registration form

    Register for the Advisory Council on the Misuse of Drugs review on MDMA (ecstasy), 26 September 2008.

  4. ACMD open meeting registration form

    Complete this form to attend the open meeting of the Advisory Council on the Misuse of Drugs in London.

  5. ACMD open meeting 12 June 2014: registration form

    Complete this form to attend the 'Diversion and Illicit Supply of Medicines Inquiry – Evidence Gathering' open meeting of the Advisory Council on the Misuse of Drugs.

See more services in this topic

Guidance and regulation

  1. Controlled drugs list
  2. Drug misuse and dependence: UK guidelines on clinical management
  3. FRANK: free practical drug advice for adults and children
  4. FRANK posters
  5. NDTMS: reference data
See more guidance and regulation in this topic

News and communications

  1. 'Third generation' synthetic cannabinoids
  2. UK-wide summit announced to tackle drug deaths
  3. Grant awarded to improve the health of people sleeping rough
  4. Dependence on prescription medicines linked to deprivation
See more news and communications in this topic

Research and statistics

  1. Substance misuse treatment for adults: statistics 2018 to 2019
  2. Review of Psychoactive Substances Act 2016: ACMD contribution
  3. Prescribed medicines review: report
  4. People who inject drugs: HIV and viral hepatitis monitoring
  5. ACMD report: ageing cohort of drug users
See more research and statistics in this topic

Policy papers and consultations

  1. NDTMS annual reports and methodology: proposed changes
  2. NDTMS criminal justice intervention teams dataset: proposed changes
  3. ACMD ageing cohort of drug users report: government response
  4. Drug related harms in homeless populations: government response
  5. Drugs policy and medicinal cannabis report: government response
See more policy papers and consultations in this topic

Transparency and freedom of information releases

  1. Commissioning impact on drug treatment
  2. Drug strategy 2016: development review
  3. Psychoactive Substances Bill: evaluation review
  4. Methiopropamine: a review of the evidence of use and harm
  5. ACMD meeting minutes, 16 May 2013
See more transparency and freedom of information releases in this topic